According to the p value and hazard ratio of gene expression in patient overall survival, the results showed that ALDOA is correlated with poor cancer prognosis, including pancreatic ductal adenocarcinoma (p=0.033, HR=1.57), LUAD (p=0.000016, HR=1.91), LIHC (p=0.000076, HR=1.99), head-neck squamous cell carcinoma (p=0.0034, HR=1.52), cervical squamous cell carcinoma (p=0.027, HR=0.68), and breast cancer (p=0.031, HR=1.42) (Figure 1B). This evidence concerns the gene ALDOA and breast cancer.